Immunocore Holdings Stock Target Price and Analyst Consensus
| IMCR Stock | USD 30.77 1.56 5.34% |
The current analyst and expert consensus on Immunocore Holdings is Strong Buy, with 1 strong sell and 7 strong buy opinions. The current projected Immunocore Holdings target price consensus is 60.91 with 15 analyst opinions. Check out Macroaxis Advice on Immunocore Holdings to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.The most common way Immunocore Holdings analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Immunocore Holdings executives and customers to further validate their buy or sell advice. Immunocore Holdings buy-or-sell recommendation module provides average expert sentiment on the projected Immunocore Holdings target price to derive its highest and lowest estimates based on projected price volatility of 2.4138.
Lowest Forecast 55.43 | Highest Forecast 67.61 | Target Price 60.91 |
Immunocore |
It's important to approach Immunocore Holdings' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Immunocore Holdings Target Price Consensus
Immunocore target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Immunocore Holdings' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 15 | Strong Buy |
Most Immunocore analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Immunocore stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Immunocore Holdings, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationImmunocore Holdings Target Price Projection
Immunocore Holdings' current and average target prices are 30.77 and 60.91, respectively. The current price of Immunocore Holdings is the price at which Immunocore Holdings is currently trading. On the other hand, Immunocore Holdings' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Immunocore Holdings Market Quote on 26th of February 2025
Target Price
Analyst Consensus On Immunocore Holdings Target Price
Immunocore Holdings Analyst Ratings
Immunocore Holdings' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Immunocore Holdings stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Immunocore Holdings' financials, market performance, and future outlook by experienced professionals. Immunocore Holdings' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Immunocore Holdings price targets
Immunocore Holdings' stock target price is an estimate of its future price, usually made by analysts. Using Immunocore Holdings' target price to determine if it is a suitable investment can be done through the following steps:- Look at Immunocore Holdings' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Immunocore Holdings' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Immunocore Holdings Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Immunocore Holdings is a key component of Immunocore Holdings valuation and have some predictive power on the future returns of a Immunocore Holdings.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunocore Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Artificial Intelligence Invested few shares | |
 | Warren Buffett Holdings Invested over 30 shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Banking Invested over 30 shares | |
 | Driverless Cars Invested few shares | |
 | Dividend Beast Invested over 60 shares | |
 | Momentum Invested few shares | |
 | Automobiles and Trucks Invested over 300 shares | |
 | Manufacturing Invested over 30 shares | |
 | Blockchain Invested over 20 shares |
Additional Tools for Immunocore Stock Analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.